Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
United States Naval Medical Center, Portsmouth
Information provided by (Responsible Party):
Geoffrey Wilson, M.D., United States Naval Medical Center, Portsmouth
ClinicalTrials.gov Identifier:
NCT01538459
First received: February 20, 2012
Last updated: May 17, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: November 2013
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)